Literature DB >> 22324965

Serum sickness and severe angioedema following rituximab therapy in RA.

Ashok Kumar, Kundan Khamkar, Hemant Gopal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22324965     DOI: 10.1111/j.1756-185X.2011.01645.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  4 in total

1.  Serum sickness following rituximab therapy in multiple sclerosis.

Authors:  Trygve Holmøy; Anna Fogdell-Hahn; Anders Svenningsson
Journal:  Neurol Clin Pract       Date:  2019-12

2.  Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness.

Authors:  Manuel Alfredo Podestà; Barbara Ruggiero; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  BMJ Case Rep       Date:  2020-01-23

Review 3.  Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Authors:  Elisa Lucchini; Francesco Zaja; James Bussel
Journal:  Haematologica       Date:  2019-05-24       Impact factor: 9.941

4.  Rituximab-Associated Flare of Cryoglobulinemic Vasculitis.

Authors:  Janina Paula T Sy-Go; Charat Thongprayoon; Loren P Herrera Hernandez; Ziad Zoghby; Nelson Leung; Sandhya Manohar
Journal:  Kidney Int Rep       Date:  2021-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.